Focused Protein Profiling Strategies and Reverse-phase Arrays Drive Growth Multiplexed protein measurements using protein microarrays have several promising applications in drug discovery and clinical ...

Expression of CD24 and CD44 tumor cells in breast cancer patients who received neoadjuvant therapy. Background: Heat shock protein 27 (HSP27) is a stress-inducible protein preventing the accumulation ...

Prognostic impact of androgen receptor (AR) and forkhead box A1 (FOXA1) in early HER2-negative primary breast cancer: A translational substudy of the prospective phase III WSG-PlanB-trial. This is an ...

The global protein chip market size is valued at USD 2.36 billion in 2025 and is predicted to hit around USD 4.98 billion by ...

Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the SARS-CoV-2 spike subunit vaccine (HexaPro) for vaccination using a patch. HexaPro, a second-generation SARS-CoV-2 ...

As illustrated by Dr. Carl Borrebaeck, [4] of Lund University, Sweden, bioarrays may be based on proteins or on affinity reagents. Defined sets of proteins, such as autoantigens, are spotted on ...

Since their inception in 1995, DNA microarrays have become the icon of the genomics revolution. Everyone with any interest has become familiar with the images of precise rows and columns of colored ...

Wildlife biologist Marissa Irwin had no idea that cells in her body had gone haywire. In response to scrambled protein signaling pathways, certain cells turned cancerous and grew into tumors that took ...

Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...

The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...